|
|
|||||||||||
|
 Company Profile CorAssist is a pre-clinical stage medical device company committed to developing innovative therapeutic products for treating diastolic heart failure. The company's proprietary technology enables the first implantation of a device that directly improves cardiac diastolic function. The company's first product, the ImCardia™, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The device assists diastolic function through reduction of filling pressures, and does not require an external power source. The company has completed early pre-clinical studies, proving the safety and efficacy of the ImCardia™, and is currently focused on preparation for clinical studies. CorAssist was founded in 2003 within the Naiot Technological Incubator by a group of three physicians, Dr. Yair Feld, Dr. Yotam Reisner and Dr. Shay Dubi, and is privately held by its investors and employees. |
|||||||||||||||||||||||||||||||||||
 |
 |